Figure A (Feiba 01)
Feiba Kit
Product Images NDC 64193-425
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Feiba (NDC 64193-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Feiba 02)
Figure C (Feiba 03)
Figure D (Feiba 04)
Figure E (Feiba 05)
Figure F (Feiba 06)
Principal Display Panel (Kit Carton)
This is a description of a medication called FEIBA, Anti-Inhibitor Coagulant Complex. It is nanofiltered and vapor heated and comes in a 20mL bottle that should be stored between 36°F and 77°F (2°C and 25°C) in its original package to protect it from light. The medication is for intravenous use after reconstitution with 20 mL SWFI, U.S.P and should be used within three hours of that process. There are certain risks associated with the product due to it being made from human plasma and components. The physician and patient should discuss these risks before use. FEIBA is a registered trademark of Baxalta Incorporated, Takeda company. The Shire Logo is a trademark of registered trademark of members of the Shire group of companies, now part of Takeda.*
Principal Display Panel (20 mL Vial Label)
This is a description of FEIBA, an Anti-Inhibitor Coagulant Complex that comes in a 20 mL size. The constitution of this product does not contain any preservative. The recommended temperature for storage ranges from 36°F to 77°F. It comes with an accompanying package insert that contains information about the administration and the constitution of the product. Reconstitution requires the use of 20 mL sWFI, U.S.P and should not be refrigerated after. The product is only to be used within 3 hours of reconstitution. It also has an NDC number 64193-324-01 and lot number.*
Principal Display Panel (Kit Carton)
FEIBA is an Anti-Inhibitor Coagulant Complex that comes in a single-dose vial. It is nanofiltered and vapor heated, and it is meant for intravenous use after reconstitution. The drug does not contain any preservatives, and it should be stored at 36°F to 77°F. The product should be used within 3 hours after reconstitution. The package insert provides instructions on dosage and administration. The product has been subjected to virus inactivation and is made from large pools of human plasma. The physician and the patient should discuss the risks and benefits of using this product. The vial label shows the Single-dose vial NDC 64193-425-02. The product also includes BAXJECT Il and BAXJECT Il Hi-Flow.*
Principal Display Panel (50 mL Vial Label)
This is a description of FEIBA, an Anti-Inhibitor Coagulant Complex designed for intravenous use after reconstitution. It comes in a 50mL size that should not be refrigerated after reconstitution, and should be used within 3 hours of reconstitution. The product does not contain any preservatives and has to be administered as per the accompanying package insert. It is stored at temperatures between 2°C to 25°C. The remaining characters do not provide any further information.*
Principal Display Panel (Kit Carton)
This is a description of a medication called FEIBA. It is a single-dose vial that is NDG 64193-426-02. This medication is an anti-inhibitor coagulant complex that has been nanofiltered and vapor heated. It is for intravenous use only and should be used within three hours of reconstitution. It should not be frozen, and after reconstitution, it should be stored at temperatures between 36°F to 77°F (2°C to 25°C) in the original package to protect it from light. The package contains a BAXJECT II Hi-Flow needleless transfer device and one package insert. The medication is made from large pools of human plasma, and the physician and the patient should discuss the risk and benefits before use. There is no standard potency for this medication.*
Principal Display Panel (10 mL Vial Label)
This is a description of a Single-dose vial of Anti-Inhibitor Coagulant Complex called FEIBA. It is a nanofiltered & vapor heated product that is used for intravenous purposes after reconstitution without a preservative. The accompanying package insert contains Dosage & Administration instructions. The product needs to be stored within 36°F to 77°F (2°C to 25°C) temperature range. The product needs to be reconstituted with 10 mL SWFI, U.S.P and should not be refrigerated after reconstitution. The product should be used within 3 hours of reconstitution. It contains a Lot No. and Exp. Date that should be monitored.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
